ConductScience.org, home

Paper7525859

ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism.

Venglarik CJ and 3 others. J Gen Physiol, 1994. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism. Papers, record 7525859. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7525859

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: evidence for a three-state activation mechanism.
PubMed
Journal
J Gen Physiol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2019-12-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Venglarik CJC J
2Schultz BDB D
3Frizzell RAR A
4Bridges RJR J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine TriphosphateMajor topic
Chloride ChannelsMajor topic
Cystic FibrosisMajor topic
Membrane ProteinsMajor topic
Animals
Computers
Cystic Fibrosis Transmembrane Conductance Regulator
Ion Channel Gating
L Cells
Mathematics
Mice
Patch-Clamp Techniques

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
DK-38518NIDDK NIH HHSUnited StatesP01DK038518PubMed and NIHNIH RePORTER
DK-42017NIDDK NIH HHSUnited StatesP50DK042017PubMed and NIHNIH RePORTER
DK-45970NIDDK NIH HHSUnited StatesR01DK045970PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
40154618A cluster of inhibitory residues in the regulatory domain prevents activation of the cystic fibrosis transmembrane conductance regulator.J Biol Chem2025https://conductscience.org/library/papers/40154618PubMed
38186087Two rare variants that affect the same amino acid in CFTR have distinct responses to ivacaftor.J Physiol2024https://conductscience.org/library/papers/38186087PubMed
34644413A small molecule CFTR potentiator restores ATP-dependent channel gating to the cystic fibrosis mutant G551D-CFTR.Br J Pharmacol2022https://conductscience.org/library/papers/34644413PubMed
32923987Pendrin stimulates a chloride absorption pathway to increase CFTR-mediated chloride secretion from Cystic Fibrosis airway epithelia.FASEB Bioadv2020https://conductscience.org/library/papers/32923987PubMed
32102849Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.J Biol Chem2020https://conductscience.org/library/papers/32102849PubMed
30969810Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR.Am J Physiol Lung Cell Mol Physiol2019https://conductscience.org/library/papers/30969810PubMed
29318594Partial rescue of F508del-cystic fibrosis transmembrane conductance regulator channel gating with modest improvement of protein processing, but not stability, by a dual-acting small molecule.Br J Pharmacol2018https://conductscience.org/library/papers/29318594PubMed
27779763Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl- channel.J Physiol2017https://conductscience.org/library/papers/27779763PubMed
24902474CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR.Br J Pharmacol2014https://conductscience.org/library/papers/24902474PubMed
24108353Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24108353PubMed
21594800Application of high-resolution single-channel recording to functional studies of cystic fibrosis mutants.Methods Mol Biol2011https://conductscience.org/library/papers/21594800PubMed
21576373Mutant cycles at CFTR's non-canonical ATP-binding site support little interface separation during gating.J Gen Physiol2011https://conductscience.org/library/papers/21576373PubMed
21447157Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.BMC Biochem2011https://conductscience.org/library/papers/21447157PubMed
20876359Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2.J Gen Physiol2010https://conductscience.org/library/papers/20876359PubMed
18957373Review. ATP hydrolysis-driven gating in cystic fibrosis transmembrane conductance regulator.Philos Trans R Soc Lond B Biol Sci2009https://conductscience.org/library/papers/18957373PubMed
18223673Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator.Br J Pharmacol2008https://conductscience.org/library/papers/18223673PubMed
17021796CFTR (ABCC7) is a hydrolyzable-ligand-gated channel.Pflugers Arch2007https://conductscience.org/library/papers/17021796PubMed
15767295CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR).J Gen Physiol2005https://conductscience.org/library/papers/15767295PubMed
15623556Normal gating of CFTR requires ATP binding to both nucleotide-binding domains and hydrolysis at the second nucleotide-binding domain.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/15623556PubMed
15596536Functional roles of nonconserved structural segments in CFTR's NH2-terminal nucleotide binding domain.J Gen Physiol2005https://conductscience.org/library/papers/15596536PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7525859

GET https://conductscience.org/api/papers/v1/7525859/cited_by?page=2